Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog)

Diabetic Medicine

Volumn 20, Issue 1, 2003, Pages 46-50

  Masson, E A ^a   Patmore, J E ^a   Brash, P D ^b   Baxter, M ^c   Caldwell, G ^d   Gallen, I W ^e   Price, P A ^f   Vice, P A ^g   Walker, J D ^h   Lindow, S W ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c ST PETER S HOSPITAL   (United Kingdom)

^d WORTHING HOSPITAL   (United Kingdom)

^e WYCOMBE HOSPITAL   (United Kingdom)

^f PRINCESS MARGARET HOSPITAL   (United Kingdom)

^g ROYAL PRESTON HOSPITAL   (United Kingdom)

^h ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Diabetes; Insulin; Insulin lispro; Pregnancy; Pregnancy outcome

Indexed keywords

INSULIN LISPRO;

ADULT; ARTICLE; BIRTH; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE CONTROL; DOWN SYNDROME; DRUG SAFETY; FEEDING DISORDER; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HAND MALFORMATION; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MATERNAL DIABETES MELLITUS; MATERNAL TREATMENT; NEWBORN DEATH; OUTCOMES RESEARCH; PARAMETER; PERINATAL MORTALITY; POLYCYTHEMIA; POLYDACTYLY; RADIUS APLASIA; RECORDING; RESPIRATORY DISTRESS SYNDROME; RETINOPATHY; SPONTANEOUS ABORTION; SYSTOLIC HEART MURMUR; TACHYPNEA; TREATMENT OUTCOME;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME;

EID: 0037240084     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00840.x     Document Type: Article

References (31)

1. Karlsson K, Kjellmer I. The outcome of diabetic pregnancies in relation to the mother's blood sugar level. Am J Obstet Gynaecol 1972; 112: 213-220.
2. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 1997; 315: 275-278.
3. Garner PR, D'Alton ME, Dudley DK, Huard P, Hardie M. Preeclampsia in diabetic pregnancies. Am J Obstet Gynaecol 1990; 163: 505-508.
4. Diamond T, Kormas N. Possible adverse fetal effect of insulin lispro. N Engl J Med 1997; 337: 1009-1010.
5. Kitzmiller JL, Main E, Ward B, Theiss T, Peterson DL. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy. Diabetes Care 1999; 22: 874-875.
6. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998; 338: 1128-1137.
7. Rubin P. Drug treatment during pregnancy. BMJ 1998; 317: 1503-1506.
8. Thalidomide's long shadow. BMJ 1976; ii: 1155-1156.
9. Anderson JH Jr, Brunelle RL, Koivisto VA, Pfutzner A, Trautmann ME, Vignati L et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment: Multicenter Insulin Lispro Study Group. Diabetes 1997; 46: 265-270.
10. Heller SR, Amiel SA, Mansell P. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. Diabetes Care 1999: 22: 1607-1611.
11. Chatterjee S, Gallen IW, Sandler L. 2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications. Diabetes Care 1999; 22: 1226-1227.
12. Koivisto VA. The human insulin analogue insulin lispro. Ann Med 1998; 30: 260-266.
13. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
14. Sadler TW, Hunter ES. Hypoglycaemia: how little is too much for the embryo. Am J Obstet Gynaecol 1987; 157: 190-193.
15. Idama T, Lindow SW, Ellis K, Masson EA. Comparison of glucose excursions following insulin lispro given before or after meals in pregnant diabetics. J Obstet Gynaecol 1999; 19 (Suppl. 1, S46): 58.
16. Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA. Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients. Diabetes Care 1998; 21: 570-573.
17. Persson B, Hansson U. Hypoglycaemia in pregnancy. Baillieres Clin Endocrinol Metab 1993; 7: 731-739.
18. Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000; 49: 999-1005.
19. Jovanovic L. Retinopathy risk: what is responsible? Hormones, hyperglycaemia, or Humalog? Diabetes Care 1999; 22: 846-848.
20. Battacharya A, Vice PA. Insulin lispro, pregnancy, and retinopathy. Diabetes Care 1999; 22: 2101-2102.
21. Buchbinder A, Miodovnik M, McElvy S, Rosenn B, Kranias G, Khoury J et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol 2000; 183: 1162-1165.
22. Star J, Carpenter MW. The effect of pregnancy on the natural history of diabetic retinopathy and nephropathy. Clin Perinatol 1998; 25: 887-916.
23. Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward Platt MP. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern diabetic pregnancy audit 1994. BMJ 1997; 315: 279-281.
24. Hadden DR. How to improve prognosis in Type 1 diabetic pregnancy. Diabetes Care 1999; 22: B104-108.
25. Atkin SL, Lindow SW, Walton C, Masson EA. Recurrent hypoglycaemia associated with first and second trimester insulin sensitivity in a patient with insulin-dependent diabetes. Diabet Med 1996; 13: 589-591.
26. DCCT Research Group. Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 1996; 174: 1343-1353.
27. Kalhan SC, Schwartz R, Adan PAJ. Placental barrier to human insulin-I125 in insulin-dependent diabetic mothers. J Clin Endocrinol Metab 1975; 40: 139-142.
28. Menon RK, Cohen RM, Sperling MA, Cutfield WS, Mimouni F, Khoury JC. Transplacental passage of insulin in pregnant women with insulin-dependant diabetes mellitus. Its role in fetal macrosomia. N Engl J Med 1990; 323: 309-315.
29. Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999; 22: 1422-1427.
30. Nachum Z, Ben-Schlomo I, Weiner E, Shalev E. Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. BMJ 1999; 319: 1223-1227.
31. Evers IM, Bos AM, Aalders AL, van Ballegooie E, de Valk HW, van Doormaal JJ et al. Pregnancy in women with diabetes mellitus type I: maternal and perinatal complications, in spite of good blood glucose control. [Dutch] Nederlands Tijdschrift voor Geneeskunde 2000; 144: 804-809.